The Bronx, NYNCT07280247Now EnrollingIRB Ready

Pulmonary Embolism Acute Clinical Trial in The Bronx, NY

Access cutting-edge pulmonary embolism acute treatment through this clinical trial at a research site in The Bronx. Study-provided care at no cost to qualified participants.

Sponsored by Angiodynamics, Inc.

Quick Self-Assessment

See if you qualify for this The Bronx location

Preparing your pre-screening questions…

Expert Care in The Bronx

Access pulmonary embolism acute specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pulmonary embolism acute treatment provided free

Apply for This The Bronx Location

Check if you qualify for this pulmonary embolism acute clinical trial in The Bronx, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to The Bronx

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit The Bronx site if eligible
  4. 4Begin participation

About This Pulmonary Embolism Acute Study in The Bronx

The investigation is intended to evaluate the safety and effectiveness of the AlphaReturn Blood Management System when used in conjunction with the cleared AlphaVac MMA F1885 System for the treatment of acute pulmonary embolism.

Sponsor: Angiodynamics, Inc.

Who Can Participate

Inclusion Criteria

A potential subject will be included in the study if he/she meets all the following inclusion criteria:
Provision of signed and dated informed consent form.
Subject is 18 years of age and older.
Subject presents clinical signs and symptoms consistent with acute intermediate-risk pulmonary embolism for less than or equal to 14 days.
Subject has a diagnosis of pulmonary embolism detected from computed tomography angiography (CTA).
Subject has a RV/LV ratio of 0.9 or higher.
Subject has a systolic blood pressure (SBP) of 90mmHg or higher.
Subject has a heart rate of 130 beats per minute (BPM) or less prior to the procedure.
Subject is deemed medically eligible for interventional procedure(s) per institutional guidelines and/or clinical judgment.

Exclusion Criteria

A potential subject will be excluded from the study if he/she meets any of the following exclusion criteria:
Subjects who are or may be pregnant as determined by a positive pregnancy test or who are breastfeeding.
Subjects who have any contraindication to systemic or therapeutic doses of heparin or anticoagulants.
Subjects who have used thrombolytics in the 30 days prior to the baseline CTA.
Subjects who have pulmonary hypertension with peak pulmonary artery pressure (PAP) \> 70 mmHg.
Subjects who have FiO2 requirement \> 44% or \> 6 LPM to keep oxygen saturations \> 90%.
Subjects with hematocrit \< 28% within 6 hours of index procedure.
Subjects with platelets count \< 100,000/μL.
Subjects with serum creatinine \> 1.8 mg/dL.
Subjects with International Normalized Ratio (INR) \> 3.
Subjects who have undergone a major trauma within the past 14 days of the index procedure and have Injury Severity Score (ISS) \> 15.
Subjects with the presence of cancer requiring active chemotherapy.
Subjects with known bleeding diathesis or coagulation disorder.
Subjects who have had a cardiovascular or pulmonary surgery within the past 7 days of index procedure.
Subjects with a history of severe or chronic pulmonary hypertension, uncompensated heart failure, chest irradiation, underlying lung disease that is oxygen dependent, heparin-induced thrombocytopenia (HIT) and/or chronic left heart disease with left ventricular ejection fraction ≤ 30%.
Subjects with known anaphylactic reaction to radiographic contrast agents that cannot be pretreated.
Subject requires vasopressor after fluids to keep pressure ≥ 90mmHg.
Subjects with left bundle branch block.
Subjects who have intracardiac lead in the right ventricle or atrium.
Evidence such as imaging or other that suggest the subject is not appropriate for this procedure.
Subjects that have life expectancy \< 90 days, in the opinion of the investigator at the time of enrollment.
Subjects dependent on extracorporeal life support such as extracorporeal membrane oxygenation (ECMO).
Participation in another investigational study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in The Bronx?

Yes, this clinical trial (NCT07280247) has an active research site in The Bronx, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pulmonary Embolism Acute Treatment Options in The Bronx, NY

If you're searching for pulmonary embolism acute treatment options in The Bronx, NY, this clinical trial (NCT07280247) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our The Bronx research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary embolism acute specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pulmonary embolism acute clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in The Bronx, NY

See all pulmonary embolism clinical trials recruiting in The Bronx — not just this study.

Browse Pulmonary Embolism Trials in The Bronx →

Browse More Trials by Condition

Pulmonary Embolism TrialsAll Conditions →

Ready to Join in The Bronx?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · The Bronx, NY